Author

Deeksha Rikhari

Institution: Motilal Nehru National Institute of Technology

Observed institution: Motilal Nehru National Institute of Technology

ORCID: 0000-0003-3134-5098

Observed ORCID: 0000-0003-3134-5098

OpenAlex ID: A5033407189

RSPO2 as Wnt signaling enabler: Important roles in cancer development and therapeutic opportunities

2023 · Ankit Srivastava, Deeksha Rikhari, et al. · Genes & Diseases · 36

An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives

2022 · Ankit Srivastava, Deeksha Rikhari, et al. · Applied Sciences · 10

Advances in Genomic Profiling of Colorectal Cancer Using Nature-Inspired Computing Techniques

2022 · Deeksha Rikhari, Ankit Srivastava, et al. · Studies in computational intelligence · 4

HIF-1α regulates the expression of the non-conventional isoform of the cd5 gene in T cells under the hypoxic condition: A potential mechanism for CD5neg/low phenotype of infiltrating cells in solid tumors

2023 · Smita Kumari, Srishti Sahu, et al. · Cellular Immunology · 3

Whole transcriptome analysis identifies ALB-EEF1A1 fusion as a novel biomarker in metastatic colorectal cancer

2025 · Deeksha Rikhari, Ankit Srivastava, et al. · Cancer Pathogenesis and Therapy · 1

Fortschritte bei der genomischen Profilerstellung von Darmkrebs mit naturinspirierten Rechentechniken

2024 · Deeksha Rikhari, Ankit Srivastava, et al. · Springer eBooks

Advancement in Nanobiotechnology for Human Health Care: Focus on Ocular Diseases and Future Prospects

2023 · Ankit Srivastava, Biswajita Pradhan, et al. · Current Nanomedicine

Neuropeptides Inhibitors for Colorectal Cancer

2022 · Srivastava, Ankit, Deeksha Rikhari, et al.

Works count: 8

Citation count: 54

H-index: 3

I10-index: 2